Glycemic control and CAD risk: a heretical thought.
Orchard
T J
TJ
D001161:Arteriosclerosis / Q000209:etiology / Q000503:physiopathology; D001786:Blood Glucose / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000503:physiopathology; D006442:Glycated Hemoglobin / Q000032:analysis*; D017127:Glycation End Products, Advanced / Q000097:blood; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D008955:Models, Cardiovascular; D012307:Risk Factors
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D017127:Glycation End Products, Advanced